MyFinsight
Home
Blog
About
Back
Income Statement
Spyre Therapeutics, Inc. (SYRE)
Spyre Therapeutics, Inc. (SYRE)
source: myfinsight.com
Net loss
-$36,200K
(-10970.34%↓ Y/Y)
Interest income
$10,053K
(71.14%↑ Y/Y)
Loss before income
tax expense
-$36,200K
(1.41%↑ Y/Y)
Total other income
(expense)
$5,439K
(4.24%↑ Y/Y)
Other (expense)
income, net
-$4,614K
(-603.35%↓ Y/Y)
Loss from operations
-$41,639K
(0.71%↑ Y/Y)
Total operating
expenses
$41,639K
(-0.71%↓ Y/Y)
Loss on sale of
in-process research and...
$40,000K
(300.00%↑ Y/Y)
Research and development
$65,503K
(63.17%↑ Y/Y)
General and
administrative
$16,136K
(36.86%↑ Y/Y)
Back